These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 10391682

  • 1. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
    de Koning JP, Soede-Bobok AA, Ward AC, Schelen AM, Antonissen C, van Leeuwen D, Löwenberg B, Touw IP.
    Oncogene; 2000 Jul 06; 19(29):3290-8. PubMed ID: 10918585
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
    Demoulin JB, Van Snick J, Renauld JC.
    Cell Growth Differ; 2001 Mar 06; 12(3):169-74. PubMed ID: 11306517
    [Abstract] [Full Text] [Related]

  • 6. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
    Klausen P, Pedersen L, Jurlander J, Baumann H.
    Oncogene; 2000 Jul 27; 19(32):3675-83. PubMed ID: 10951574
    [Abstract] [Full Text] [Related]

  • 7. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
    Lin SK, Kok SH, Yeh FT, Kuo MY, Lin CC, Wang CC, Goldring SR, Hong CY.
    Arthritis Rheum; 2004 Mar 27; 50(3):785-93. PubMed ID: 15022320
    [Abstract] [Full Text] [Related]

  • 8. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H, Baumann H.
    Mol Cell Biol; 1999 Aug 12; 19(8):5326-38. PubMed ID: 10409724
    [Abstract] [Full Text] [Related]

  • 11. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T.
    EMBO J; 1996 Apr 01; 15(7):1557-65. PubMed ID: 8612579
    [Abstract] [Full Text] [Related]

  • 12. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, Fridman WH, Tartour E.
    Clin Cancer Res; 1997 Aug 01; 3(8):1443-51. PubMed ID: 9815830
    [Abstract] [Full Text] [Related]

  • 13. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 14. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
    Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA, Baumann H.
    Hepatology; 1999 Sep 28; 30(3):682-97. PubMed ID: 10462375
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C, Berreur M, Couillaud S, Pradal G, Vallette F, Colombeix C, Rédini F, Heymann D, Blanchard F.
    J Bone Miner Res; 2004 Nov 28; 19(11):1850-61. PubMed ID: 15476586
    [Abstract] [Full Text] [Related]

  • 16. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 17. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ, Jelinek DF.
    J Immunol; 1996 Oct 01; 157(7):3081-8. PubMed ID: 8816418
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
    Reichert TE, Nagashima S, Kashii Y, Stanson J, Gao G, Dou QP, Whiteside TL.
    Oncogene; 2000 Jan 27; 19(4):514-25. PubMed ID: 10698521
    [Abstract] [Full Text] [Related]

  • 19. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
    Nakaoka Y, Nishida K, Fujio Y, Izumi M, Terai K, Oshima Y, Sugiyama S, Matsuda S, Koyasu S, Yamauchi-Takihara K, Hirano T, Kawase I, Hirota H.
    Circ Res; 2003 Aug 08; 93(3):221-9. PubMed ID: 12855672
    [Abstract] [Full Text] [Related]

  • 20. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999 Aug 08; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.